Steven Cohen Reported 5.7% Passive Stake In Cheniere Energy

Steven Cohen – SAC Capital Advisors disclosed 5.7% passive stake in Cheniere Energy Inc. (LNG) on December 29th. According to a regulatory filing, Steven Cohen now has 7.17 million shares of LNG, which is a 686% expansion in his position. In the third quarter, Steven Cohen reported 1.04 million shares in LNG. It’s possible that Steven Cohen foresaw LNG’s surge and bought most shares during October. LNG has returned more than 50% in 2011. The stock is now trading at $8.57.

SAC CAPITAL ADVISORS

Steven Cohen isn’t Cheniere Energy’s biggest stakeholder. In the third quarter, John Kleinheinz’s Kleinheinz Capital Partners retained exactly 4 million shares in the stock, unchanged from the previous quarter. David E. Shaw’s D. E. Shaw boosted its position by 59% and had 2.75 million shares as of the end of September.

Stamford, Connecticut-based SAC Capital is founded by Steven Cohen in 1992. SAC is a diversified hedge fund that uses both fundamental and quantitative analysis based approaches. Cohen is one of the legendary traders and a billionaire. He is estimated to have an $8 Billion new worth. Steve Cohen has $14 Billion in AUM and returned nearly 30% during the past 20 years.

Cheniere Energy, Inc. is “an energy company primarily engaged in liquefied natural gas (LNG)-related businesses”, according to Google Finance. The company “owns and operates the Sabine Pass LNG terminal in Louisiana through its 90.6% ownership interest in and management agreements with Cheniere Energy Partners, L.P. Cheniere operates in three business segments: LNG terminal business, natural gas pipeline business and LNG and natural gas marketing business.”

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!